Overview A Study of Galcanezumab in Participants With Chronic Cluster Headache Status: Completed Trial end date: 2019-08-14 Target enrollment: Participant gender: Summary The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic cluster headache. Phase: Phase 3 Details Lead Sponsor: Eli Lilly and Company